Global Dry Eye Syndrome Treatment Market Size study, By Product Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements, Others), By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmac

Global Dry Eye Syndrome Treatment Market Size study, By Product Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements, Others), By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2028

Global Dry Eye Syndrome Treatment Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Dry eye syndrome is a condition that affects the surface of a person's eyes, in which a shortage of moisture or lubrication is created in the eye. Red eyes, photophobia, aching and burning sensations, itchy eyes, weary eyes, sore eyes, and further symptoms occur in dry eye syndrome. The rising prevalence of dry eye disease cases, growing adoption of various treatments such as artificial tears and dry eye treatment drops, coupled with the growing geriatric population are the several key factors burgeoning the market demand across the globe. For instance, according to Statista, the dry eye syndrome market was worth approximately USD 3.5 billion in 2018. Also, it is projected that the amount rapidly increases and is likely to reach around USD 5.1 billion by the year 2024. Consequentially, the growth of the dry eye syndrome market is positively influencing the demand for dry eye syndrome treatment, which is accelerating the market growth in the impending years. However, poor availability of certain products across emerging economies and lack of awareness about dry eye disease impede the growth of the market over the forecast period of 2022-2028. Also, the increasing popularity of excimer and femtosecond ophthalmic lasers for treating dry eye syndrome, as well as, increasing healthcare expenditure, are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Dry Eye Syndrome Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising presence of leading pharmaceutical manufacturers, along with the growth of eyecare products market. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rise in the number of research and development activities for the development of new treatments, and growing consumers’ awareness regarding the availability of dry eye disease treatment alternatives, would create lucrative growth prospects for the Dry Eye Syndrome Treatment Market across the Asia-Pacific region.

Major market players included in this report are:
Novartis AG
Otsuka Pharmaceuticals Co., Ltd.
Bausch Health Companies, Inc.
Akron, Inc.
Johnson & Johnson, Inc.
Thea Pharmaceuticals Limited
Altaire Pharmaceuticals Inc.
Similasan Corporation
Scope Ophthalmics Ltd.
Reckitt Benckiser Group PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Cyclosporine
Topical Corticosteroids
Artificial Tears
Punctal Plugs
Oral Omega Supplements
Others
By Distribution Channel:
Hospital Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Dry Eye Syndrome Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Novartis AG
Otsuka Pharmaceuticals Co., Ltd.
Bausch Health Companies, Inc.
Akron, Inc.
Johnson & Johnson, Inc.
Thea Pharmaceuticals Limited
Altaire Pharmaceuticals Inc.
Similasan Corporation
Scope Ophthalmics Ltd.
Reckitt Benckiser Group PLC

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.